Erectile dysfunction (ED) affects millions of men worldwide, leading many to seek convenient and discreet treatment options. Hims, an online telehealth platform, offers consultations and ...

Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...

Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...

Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...

Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...

Bearish flow noted in Hims and Hers Health with 25,948 puts trading, or 1.4x expected. Most active are Mar-25 27 puts and Jan-25 26 puts, with total volume in those strikes near 12,400 contracts.

Hims & Hers sells compounded GLP-1 agonists, which have become its identity in the eyes of the market. The company is poised to grow, even if it must shut down its compounded GLP-1 agonist ...

BTIG initiated coverage of Hims & Hers with a Buy rating and $35 price target The firm says its likes Hims & Hers because of its “disruptive” business model approach that delivers health ...

Hot telehealth stock Hims & Hers Health (NYSE: HIMS) has been a roller coaster in 2024. After a recent decline, the stock is down more than 25% from its high. Yet Hims & Hers is still up nearly ...